Autolus Therapeutics plc announced two changes to the company's Board of Directors. The company's non-executive Chairman, John H Johnson, who has held the role since September 2021, will not stand for re-election at Autolus' upcoming annual shareholder meeting. During his tenure as Chairman of Autolus he was appointed as Chief Executive Officer of Reaction Biology and will focus his time on his operational role.

Additionally, Dr. Jay T Backstrom, who has served on Autolus' Board of Directors since August 2020, will step down from Autolus' Board of Directors at the end of February 2023. Dr. Backstrom was recently appointed as CEO of Scholar Rock and will focus his time on his operational role in line with good governance recommendations for public company CEOs.